✦ LIBER ✦

Trimethylsilylpyrazoles as novel inhibitors of p38 MAP kinase: A new use of silicon bioisosteres in medicinal chemistry

✍ Scribed by Matthew J. Barnes; Richard Conroy; David J. Miller; John S. Mills; John G. Montana; Parminder K. Pooni; Graham A. Showell; Louise M. Walsh; Julie B.H. Warneck

Book ID: 108074200
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 176 KB
Volume: 17
Category: Article
ISSN: 0960-894X
DOI: 10.1016/j.bmcl.2006.10.044

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trimethylsilylpyrazoles as Novel Inhibit

Trimethylsilylpyrazoles as Novel Inhibitors of p38 MAP Kinase: A New Use of Silicon Bioisosteres in Medicinal Chemistry.

✍ Matthew J. Barnes; Richard Conroy; David J. Miller; John S. Mills; John G. Monta 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 27 KB 👁 1 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

5-Cyanopyrimidine Derivatives as a Novel

5-Cyanopyrimidine Derivatives as a Novel Class of Potent, Selective, and Orally Active Inhibitors of p38α MAP Kinase

✍ Liu, Chunjian; Wrobleski, Stephen T.; Lin, James; Ahmed, Gulzar; Metzger, Axel; 📂 Article 📅 2005 🏛 American Chemical Society 🌐 English ⚖ 297 KB

Transition Metal-Catalyzed Couplings in

Transition Metal-Catalyzed Couplings in Process Chemistry || Development of a Practical Synthesis of Naphthyridone p38 MAP Kinase Inhibitor MK-0913

✍ Magano, Javier; Dunetz, Joshua R. 📂 Article 📅 2013 🏛 Wiley-VCH Verlag GmbH & Co. KGaA 🌐 German ⚖ 238 KB

Utilization of a nitrogen–sulfur nonbond

Utilization of a nitrogen–sulfur nonbonding interaction in the design of new 2-aminothiazol-5-yl-pyrimidines as p38α MAP kinase inhibitors

✍ Shuqun Lin; Stephen T. Wrobleski; John Hynes Jr.; Sidney Pitt; Rosemary Zhang; Y 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 770 KB

Analgesic efficacy and safety of the nov

Analgesic efficacy and safety of the novel p38 MAP kinase inhibitor, losmapimod, in patients with neuropathic pain following peripheral nerve injury: a double-blind, placebo-controlled study

✍ Ostenfeld, T.; Krishen, A.; Lai, R.Y.; Bullman, J.; Baines, A.J.; Green, J.; Ana 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 485 KB

Novel Inhibitor of p38 MAP Kinase as an

Novel Inhibitor of p38 MAP Kinase as an Anti-TNF-α Drug: Discovery of N -[4-[2-Ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide (TAK-715) as a Potent and Orally Active Anti-Rheumatoid Arthritis Agent

✍ Miwatashi, Seiji; Arikawa, Yasuyoshi; Kotani, Etsuo; Miyamoto, Maki; Naruo, Ken- 📂 Article 📅 2005 🏛 American Chemical Society 🌐 English ⚖ 382 KB